CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- 4 Open-market buy 10% owner bought 2,000 shares at $14.00 ($28,000)
- 4 Open-market buy Director bought 2,000 shares at $14.00 ($28,000)
- 4 Open-market buy Director bought 2,000 shares at $14.00 ($28,000)
- 4 Open-market buy 10% owner bought 2,000 shares at $14.00 ($28,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 1,000 shares at $14.00 ($14,000)
- 4 Open-market buy Director bought 1,000 shares at $14.00 ($14,000)
- 4 Open-market buy 10% owner bought 2,000 shares at $12.00 ($24,000)
- 4 Open-market buy Director bought 2,000 shares at $12.00 ($24,000)
- 4 Open-market buy Director bought 3,750 shares at $14.12 ($52,950)
- 4 Open-market buy 10% owner bought 3,750 shares at $14.12 ($52,950)
- 4 Open-market buy Director bought 10,000 shares at $14.34 ($143,400)
- 4 Open-market buy 10% owner bought 10,000 shares at $14.34 ($143,400)
- 4 Open-market buy 10% owner bought 2,183 shares at $15.02 ($32,789)
- 4 Open-market buy Director bought 2,183 shares at $15.02 ($32,789)
- 4 Open-market buy 10% owner bought 817 shares at $15.25 ($12,459)
- 4 Open-market buy Director bought 817 shares at $15.25 ($12,459)
- 4 Open-market buy Director bought 1,000 shares at $15.25 ($15,249)
- 4 Open-market buy 10% owner bought 1,000 shares at $15.25 ($15,249)
Page 10 of 13 · 245 filings